Prelude Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,890
Closed -$183K 1833
2021
Q4
$183K Sell
6,890
-2,910
-30% -$77.3K ﹤0.01% 1242
2021
Q3
$356K Hold
9,800
0.01% 791
2021
Q2
$425K Buy
9,800
+1,300
+15% +$56.4K 0.01% 827
2021
Q1
$291K Hold
8,500
0.01% 805
2020
Q4
$298K Hold
8,500
0.01% 517
2020
Q3
$204K Buy
8,500
+2,500
+42% +$60K 0.01% 499
2020
Q2
$110K Buy
+6,000
New +$110K 0.01% 635
2020
Q1
Sell
-476
Closed -$10K 1448
2019
Q4
$10K Sell
476
-75
-14% -$1.58K ﹤0.01% 1241
2019
Q3
$10K Sell
551
-404
-42% -$7.33K ﹤0.01% 1017
2019
Q2
$25K Buy
955
+312
+49% +$8.17K ﹤0.01% 895
2019
Q1
$17K Sell
643
-101
-14% -$2.67K ﹤0.01% 971
2018
Q4
$17K Buy
744
+56
+8% +$1.28K ﹤0.01% 944
2018
Q3
$22K Buy
688
+61
+10% +$1.95K ﹤0.01% 952
2018
Q2
$18K Buy
627
+36
+6% +$1.03K ﹤0.01% 1099
2018
Q1
$21K Buy
591
+29
+5% +$1.03K ﹤0.01% 1109
2017
Q4
$22K Buy
+562
New +$22K ﹤0.01% 996
2017
Q3
Sell
-969
Closed -$26K 1726
2017
Q2
$26K Buy
969
+489
+102% +$13.1K ﹤0.01% 1091
2017
Q1
$16K Buy
480
+440
+1,100% +$14.7K ﹤0.01% 1238
2016
Q4
$1K Sell
40
-410
-91% -$10.3K ﹤0.01% 1452
2016
Q3
$17K Sell
450
-2,450
-84% -$92.6K ﹤0.01% 1293
2016
Q2
$65K Buy
2,900
+410
+16% +$9.19K 0.01% 859
2016
Q1
$52K Buy
2,490
+420
+20% +$8.77K 0.01% 894
2015
Q4
$63K Sell
2,070
-935
-31% -$28.5K 0.01% 921
2015
Q3
$74K Buy
3,005
+2,530
+533% +$62.3K 0.01% 859
2015
Q2
$15K Buy
+475
New +$15K ﹤0.01% 1411